Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3818928)

Published in BMC Infect Dis on November 01, 2013

Authors

Matthias Willmann1, Ines Kuebart, Matthias Marschal, Klaus Schröppel, Wichard Vogel, Ingo Flesch, Uwe Markert, Ingo B Autenrieth, Florian Hölzl, Silke Peter

Author Affiliations

1: Institute of Medical Microbiology and Hygiene, University of Tübingen, Elfriede-Aulhorn-Str, 6, 72076 Tübingen, Germany. will80@gmx.de.

Articles cited by this

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA (1994) 27.36

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43

Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect Dis (2011) 6.00

New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis (2001) 4.17

The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med (2005) 4.07

Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis (2010) 3.23

Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis (2003) 3.20

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother (2006) 3.09

Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory. J Clin Microbiol (2005) 2.89

EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect (2011) 2.65

In70 of plasmid pAX22, a bla(VIM-1)-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob Agents Chemother (2001) 2.29

Clinical outcomes of type III Pseudomonas aeruginosa bacteremia. Crit Care Med (2012) 2.03

Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother (2007) 1.91

Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains. J Infect Dis (2005) 1.80

Establishing clonal relationships between VIM-1-like metallo-beta-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. J Clin Microbiol (2006) 1.72

Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis (2003) 1.70

Spread of bla(VIM-1)-producing E. coli in a university hospital in Greece. Genetic analysis of the integron carrying the bla(VIM-1) metallo-beta-lactamase gene. Diagn Microbiol Infect Dis (2004) 1.60

Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis (2007) 1.43

Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes. Infect Control Hosp Epidemiol (2010) 1.30

The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother (2006) 1.26

Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother (2012) 1.20

Molecular characterisation of the metallo-beta-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. Int J Antimicrob Agents (2008) 1.14

Trend analysis of antimicrobial consumption and development of resistance in non-fermenters in a tertiary care hospital in Delhi, India. J Antimicrob Chemother (2011) 1.12

Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections. Infection (2009) 1.04

Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother (2007) 1.02

Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Epidemiol Infect (2011) 0.97

Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis. Intern Med (2011) 0.96

Pseudomonas aeruginosa: clinical manifestations and management. Lancet (1985) 0.90

First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital. Antimicrob Agents Chemother (2010) 0.88

Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands. Eur J Clin Microbiol Infect Dis (2012) 0.88

Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (2013) 0.86

A model to predict mortality following Pseudomonas aeruginosa bacteremia. Diagn Microbiol Infect Dis (2011) 0.80

Articles by these authors

Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell (2003) 3.68

Fungal adenylyl cyclase integrates CO2 sensing with cAMP signaling and virulence. Curr Biol (2005) 2.42

Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci (2007) 2.24

Vascular closure staples-a new technique for biliary reconstruction: prospective randomized comparison with manual suture in an animal model. Transplantation (2002) 2.02

Trimeric autotransporter adhesins: variable structure, common function. Trends Microbiol (2006) 2.02

Large-conductance calcium-activated potassium channel activity is absent in human and mouse neutrophils and is not required for innate immunity. Am J Physiol Cell Physiol (2007) 1.99

Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J Med Microbiol (2009) 1.97

Bartonella adhesin a mediates a proangiogenic host cell response. J Exp Med (2004) 1.84

Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology (2003) 1.53

Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation (2005) 1.52

Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations. J Rheumatol (2012) 1.46

Calcineurin is essential for virulence in Candida albicans. Infect Immun (2003) 1.46

High diversity of ankA sequences of Anaplasma phagocytophilum among Ixodes ricinus ticks in Germany. J Clin Microbiol (2003) 1.41

Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J Clin Microbiol (2005) 1.38

PMT family of Candida albicans: five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance. Mol Microbiol (2005) 1.37

Subcapsular liver hematoma in HELLP syndrome: Evaluation of diagnostic and therapeutic options--a unicenter study. Am J Obstet Gynecol (2004) 1.33

Role of calcineurin in stress resistance, morphogenesis, and virulence of a Candida albicans wild-type strain. Infect Immun (2006) 1.32

Gene-environment interactions in chronic inflammatory disease. Nat Immunol (2011) 1.30

Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology (2007) 1.29

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. Blood Cells Mol Dis (2007) 1.27

Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device. Cytotherapy (2013) 1.23

Profile of Candida albicans-secreted aspartic proteinase elicited during vaginal infection. Infect Immun (2005) 1.21

cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. Antimicrob Agents Chemother (2013) 1.19

Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model. PLoS Pathog (2009) 1.16

Rapid identification of Staphylococcus aureus in blood cultures by a combination of fluorescence in situ hybridization using peptide nucleic acid probes and flow cytometry. J Clin Microbiol (2005) 1.14

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study. Haematologica (2012) 1.14

Infection of human CD34+ progenitor cells with Bartonella henselae results in intraerythrocytic presence of B. henselae. Blood (2005) 1.12

Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes. J Clin Microbiol (2009) 1.12

Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study. Blood (2010) 1.10

Preliminary evaluation of one conventional nested and two real-time PCR assays for the detection of Toxoplasma gondii in immunocompromised patients. J Med Microbiol (2004) 1.09

A conserved glycine residue of trimeric autotransporter domains plays a key role in Yersinia adhesin A autotransport. J Bacteriol (2007) 1.08

IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cells. J Immunol (2007) 1.08

Forced IFIT-2 expression represses LPS induced TNF-alpha expression at posttranscriptional levels. BMC Immunol (2008) 1.07

BK channels in innate immune functions of neutrophils and macrophages. Blood (2008) 1.07

Yersinia enterocolitica induces apoptosis and inhibits surface molecule expression and cytokine production in murine dendritic cells. Infect Immun (2004) 1.06

Yersinia enterocolitica adhesin A induces production of interleukin-8 in epithelial cells. Infect Immun (2004) 1.04

Two episodes of vancomycin-resistant Enterococcus faecium outbreaks caused by two genetically different clones in a newborn intensive care unit. Int J Hyg Environ Health (2004) 1.03

Immunomodulation by semi-mature dendritic cells: a novel role of Toll-like receptors and interleukin-6. Int J Med Microbiol (2009) 1.03

The moonlighting protein Tsa1p is implicated in oxidative stress response and in cell wall biogenesis in Candida albicans. Mol Microbiol (2005) 1.00

Interaction of Yersinia enterocolitica with epithelial cells: invasin beyond invasion. Int J Med Microbiol (2003) 0.98

Severe diarrhoea caused by Aeromonas veronii biovar sobria in a patient with metastasised GIST. Pol J Microbiol (2007) 0.98

Depletion of dendritic cells enhances innate anti-bacterial host defense through modulation of phagocyte homeostasis. PLoS Pathog (2012) 0.98

Monoclonal antibody 9C4 recognizes epithelial cellular adhesion molecule, a cell surface antigen expressed in early steps of erythropoiesis. Exp Hematol (2002) 0.98

Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance. Intensive Care Med (2006) 0.98

Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics. Infect Immun (2007) 0.97

Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. Inflamm Bowel Dis (2007) 0.97

Symptomatic bone marrow involvement in breast cancer--clinical presentation, treatment, and prognosis: a single institution review of 22 cases. Anticancer Res (2011) 0.97

Activation of NF-kappaB and IL-8 by Yersinia enterocolitica invasin protein is conferred by engagement of Rac1 and MAP kinase cascades. Cell Microbiol (2003) 0.95

Ureaplasma urealyticum meningitis in an adult patient. J Clin Microbiol (2008) 0.95

Characterization of an Enterococcus faecium small-colony variant isolated from blood culture. Int J Med Microbiol (2011) 0.94

Radiologic spectrum of extramedullary relapse of myelogenous leukemia in adults. AJR Am J Roentgenol (2007) 0.94

Bacteria induce CTGF and CYR61 expression in epithelial cells in a lysophosphatidic acid receptor-dependent manner. Int J Med Microbiol (2007) 0.94

Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells. Apoptosis (2007) 0.93

Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae. Int J Med Microbiol (2007) 0.93

Bartonella henselae inhibits apoptosis in Mono Mac 6 cells. Cell Microbiol (2005) 0.93

Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host. Infect Immun (2010) 0.92

Yersinia YopP-induced apoptotic cell death in murine dendritic cells is partially independent from action of caspases and exhibits necrosis-like features. Apoptosis (2006) 0.92

Induction of CD8+ T cell responses by Yersinia vaccine carrier strains. Vaccine (2005) 0.92

Evaluation of 3 different rapid automated systems for diagnosis of urinary tract infections. Diagn Microbiol Infect Dis (2011) 0.92

Do plant and human pathogens have a common pathogenicity strategy? Trends Microbiol (2002) 0.91

Yersinia enterocolitica YopP inhibits MAP kinase-mediated antigen uptake in dendritic cells. Cell Microbiol (2006) 0.90

Host gene expression in the colon of gnotobiotic interleukin-2-deficient mice colonized with commensal colitogenic or noncolitogenic bacterial strains: common patterns and bacteria strain specific signatures. Inflamm Bowel Dis (2006) 0.90

Rapid detection and identification of pathogens in blood cultures by fluorescence in situ hybridization and flow cytometry. Int J Med Microbiol (2005) 0.89

Yersinia outer proteins E, H, P, and T differentially target the cytoskeleton and inhibit phagocytic capacity of dendritic cells. Int J Med Microbiol (2007) 0.89

Bartonella quintana variably expressed outer membrane proteins mediate vascular endothelial growth factor secretion but not host cell adherence. Infect Immun (2006) 0.89

Induction of SAP7 correlates with virulence in an intravenous infection model of candidiasis but not in a vaginal infection model in mice. Infect Immun (2005) 0.88

IFIT2 is an effector protein of type I IFN-mediated amplification of lipopolysaccharide (LPS)-induced TNF-α secretion and LPS-induced endotoxin shock. J Immunol (2013) 0.88

Intimin and invasin export their C-terminus to the bacterial cell surface using an inverse mechanism compared to classical autotransport. PLoS One (2012) 0.88

Proteomic analysis of the bacterial pathogen Bartonella henselae and identification of immunogenic proteins for serodiagnosis. Proteomics (2009) 0.88

Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia. Ann Hematol (2013) 0.87

Rapid screening for Streptococcus agalactiae in vaginal specimens of pregnant women by fluorescent in situ hybridization. J Clin Microbiol (2003) 0.87

Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (2013) 0.86

Yersinia enterocolitica YadA mediates complement evasion by recruitment and inactivation of C3 products. J Immunol (2012) 0.86

Autodisplay: development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains. Infect Immun (2003) 0.86

Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: an important role for IL-6. Eur J Immunol (2006) 0.85

Gene-environment interaction in chronic disease: a European Science Foundation Forward Look. J Allergy Clin Immunol (2011) 0.85

Rapid and efficient transposon mutagenesis of Bartonella henselae by transposome technology. Gene (2003) 0.85

Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo. PLoS Pathog (2010) 0.85

Monoclonal outbreak of catheter-related bacteraemia by Ralstonia mannitolilytica on two haemato-oncology wards. J Infect (2007) 0.85

Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy. BMJ Case Rep (2009) 0.85

Mitochondria can recognize and assemble fragments of a beta-barrel structure. Mol Biol Cell (2011) 0.84

Tec1p-independent activation of a hypha-associated Candida albicans virulence gene during infection. Infect Immun (2004) 0.84

Parkinson's disease-associated DJ-1 modulates innate immunity signaling in Caenorhabditis elegans. J Neural Transm (Vienna) (2010) 0.84

Role of IFN-gamma and IL-6 in a protective immune response to Yersinia enterocolitica in mice. BMC Microbiol (2008) 0.84

Attenuated Yersinia enterocolitica mutant strains exhibit differential virulence in cytokine-deficient mice: implications for the development of novel live carrier vaccines. Infect Immun (2003) 0.84

Hydro-Jet assisted laparroscopic cholecystectomy: initial experience in a porcine model. JSLS (2002) 0.83

New blood vessel formation and expression of VEGF receptors after implantation of platelet growth factor-enriched biodegradable nanocrystalline hydroxyapatite. Growth Factors (2005) 0.83

Shared cell surface marker expression in mesenchymal stem cells and adult sarcomas. Stem Cells Transl Med (2012) 0.83

Y. enterocolitica inhibits antigen degradation in dendritic cells. Microbes Infect (2008) 0.82

Rifampicin induces MDR1 expression in Candida albicans. J Antimicrob Chemother (2008) 0.82

Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approaches. Clin Cancer Res (2003) 0.82

Yersinia enterocolitica: subversion of adaptive immunity and implications for vaccine development. Int J Med Microbiol (2007) 0.82

Lymphoscintigraphy in patients with primary rectal cancer: the role of total mesorectal excision for primary rectal cancer--a lymphoscintigraphic study. Int J Colorectal Dis (2002) 0.81

The Intimin periplasmic domain mediates dimerisation and binding to peptidoglycan. Mol Microbiol (2014) 0.81

Differential roles of Yersinia outer protein P-mediated inhibition of nuclear factor-kappa B in the induction of cell death in dendritic cells and macrophages. J Med Microbiol (2008) 0.81